FdaApplication
NDA 209299
Identifiers
- fda_app_no: NDA209299
Properties
| Property | Value |
|---|---|
| applicant_name | RIGEL PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2018-04-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAVALISSE | FOSTAMATINIB DISODIUM | EQ 150MG BASE | TABLET;ORAL |
| TAVALISSE | FOSTAMATINIB DISODIUM | EQ 100MG BASE | TABLET;ORAL |
2 products